nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—Capecitabine—stomach cancer	0.449	0.577	CbGbCtD
Ciclesonide—CES1—Irinotecan—stomach cancer	0.277	0.357	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—stomach cancer	0.0164	0.021	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—stomach cancer	0.0141	0.0181	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—stomach cancer	0.012	0.0154	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—stomach cancer	0.00894	0.0115	CbGbCtD
Ciclesonide—CES1—gall bladder—stomach cancer	0.0038	0.132	CbGeAlD
Ciclesonide—Amcinonide—ANXA1—stomach cancer	0.00231	0.602	CrCbGaD
Ciclesonide—CES1—hematopoietic system—stomach cancer	0.00215	0.075	CbGeAlD
Ciclesonide—SERPINA6—hematopoietic system—stomach cancer	0.00215	0.0749	CbGeAlD
Ciclesonide—CES1—lymphoid tissue—stomach cancer	0.00152	0.0528	CbGeAlD
Ciclesonide—CES1—digestive system—stomach cancer	0.0015	0.0521	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—stomach cancer	0.00138	0.048	CbGeAlD
Ciclesonide—CES1—endocrine gland—stomach cancer	0.00124	0.0431	CbGeAlD
Ciclesonide—SERPINA6—endocrine gland—stomach cancer	0.00124	0.043	CbGeAlD
Ciclesonide—CES1—liver—stomach cancer	0.00112	0.0388	CbGeAlD
Ciclesonide—SERPINA6—liver—stomach cancer	0.00111	0.0388	CbGeAlD
Ciclesonide—Hydrocortisone—ANXA1—stomach cancer	0.000973	0.254	CrCbGaD
Ciclesonide—NR3C1—hematopoietic system—stomach cancer	0.000942	0.0328	CbGeAlD
Ciclesonide—NR3C1—epithelium—stomach cancer	0.000861	0.03	CbGeAlD
Ciclesonide—CES1—lymph node—stomach cancer	0.000855	0.0298	CbGeAlD
Ciclesonide—NR3C1—smooth muscle tissue—stomach cancer	0.00083	0.0289	CbGeAlD
Ciclesonide—NR3C1—pancreas—stomach cancer	0.000767	0.0267	CbGeAlD
Ciclesonide—CYP3A4—hematopoietic system—stomach cancer	0.000712	0.0248	CbGeAlD
Ciclesonide—CYP2D6—hematopoietic system—stomach cancer	0.000701	0.0244	CbGeAlD
Ciclesonide—NR3C1—lymphoid tissue—stomach cancer	0.000663	0.0231	CbGeAlD
Ciclesonide—NR3C1—digestive system—stomach cancer	0.000655	0.0228	CbGeAlD
Ciclesonide—NR3C1—bone marrow—stomach cancer	0.000604	0.021	CbGeAlD
Ciclesonide—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.000571	0.00409	CcSEcCtD
Ciclesonide—Swelling—Capecitabine—stomach cancer	0.000563	0.00404	CcSEcCtD
Ciclesonide—Gastroenteritis—Capecitabine—stomach cancer	0.000561	0.00402	CcSEcCtD
Ciclesonide—Dizziness—Mitomycin—stomach cancer	0.000556	0.00398	CcSEcCtD
Ciclesonide—Pneumonia—Fluorouracil—stomach cancer	0.000551	0.00395	CcSEcCtD
Ciclesonide—Infestation NOS—Fluorouracil—stomach cancer	0.000548	0.00393	CcSEcCtD
Ciclesonide—Infestation—Fluorouracil—stomach cancer	0.000548	0.00393	CcSEcCtD
Ciclesonide—NR3C1—endocrine gland—stomach cancer	0.000541	0.0188	CbGeAlD
Ciclesonide—Ulcer—Methotrexate—stomach cancer	0.000539	0.00386	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—stomach cancer	0.000536	0.00384	CcSEcCtD
Ciclesonide—Conjunctivitis—Fluorouracil—stomach cancer	0.000533	0.00382	CcSEcCtD
Ciclesonide—Urinary tract infection—Fluorouracil—stomach cancer	0.000533	0.00382	CcSEcCtD
Ciclesonide—Rash—Mitomycin—stomach cancer	0.00053	0.0038	CcSEcCtD
Ciclesonide—Dermatitis—Mitomycin—stomach cancer	0.000529	0.00379	CcSEcCtD
Ciclesonide—Headache—Mitomycin—stomach cancer	0.000527	0.00377	CcSEcCtD
Ciclesonide—Epistaxis—Fluorouracil—stomach cancer	0.000517	0.0037	CcSEcCtD
Ciclesonide—Haemoglobin—Irinotecan—stomach cancer	0.000516	0.0037	CcSEcCtD
Ciclesonide—Rhinitis—Irinotecan—stomach cancer	0.000515	0.00369	CcSEcCtD
Ciclesonide—Sinusitis—Fluorouracil—stomach cancer	0.000514	0.00369	CcSEcCtD
Ciclesonide—Haemorrhage—Irinotecan—stomach cancer	0.000514	0.00368	CcSEcCtD
Ciclesonide—Pain in extremity—Docetaxel—stomach cancer	0.000513	0.00368	CcSEcCtD
Ciclesonide—Ulcer—Epirubicin—stomach cancer	0.000504	0.00361	CcSEcCtD
Ciclesonide—Nausea—Mitomycin—stomach cancer	0.000499	0.00358	CcSEcCtD
Ciclesonide—Pain in extremity—Capecitabine—stomach cancer	0.000497	0.00356	CcSEcCtD
Ciclesonide—CYP3A4—digestive system—stomach cancer	0.000495	0.0172	CbGeAlD
Ciclesonide—Haemoglobin—Fluorouracil—stomach cancer	0.000495	0.00354	CcSEcCtD
Ciclesonide—Rhinitis—Fluorouracil—stomach cancer	0.000493	0.00354	CcSEcCtD
Ciclesonide—Haemorrhage—Fluorouracil—stomach cancer	0.000492	0.00353	CcSEcCtD
Ciclesonide—Pharyngitis—Fluorouracil—stomach cancer	0.000488	0.0035	CcSEcCtD
Ciclesonide—NR3C1—liver—stomach cancer	0.000488	0.017	CbGeAlD
Ciclesonide—CYP2D6—digestive system—stomach cancer	0.000488	0.017	CbGeAlD
Ciclesonide—Face oedema—Capecitabine—stomach cancer	0.00048	0.00344	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—stomach cancer	0.000467	0.00334	CcSEcCtD
Ciclesonide—Immune system disorder—Irinotecan—stomach cancer	0.000464	0.00333	CcSEcCtD
Ciclesonide—Mediastinal disorder—Irinotecan—stomach cancer	0.000463	0.00332	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—stomach cancer	0.000459	0.00329	CcSEcCtD
Ciclesonide—Candida infection—Epirubicin—stomach cancer	0.000455	0.00326	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000453	0.00324	CcSEcCtD
Ciclesonide—Nasopharyngitis—Capecitabine—stomach cancer	0.000444	0.00319	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000438	0.00314	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—stomach cancer	0.000436	0.00313	CcSEcCtD
Ciclesonide—Back pain—Irinotecan—stomach cancer	0.000433	0.0031	CcSEcCtD
Ciclesonide—Influenza—Capecitabine—stomach cancer	0.00043	0.00308	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methotrexate—stomach cancer	0.000425	0.00305	CcSEcCtD
Ciclesonide—Bronchospasm—Capecitabine—stomach cancer	0.000423	0.00303	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—stomach cancer	0.000421	0.00302	CcSEcCtD
Ciclesonide—Bronchitis—Capecitabine—stomach cancer	0.000413	0.00296	CcSEcCtD
Ciclesonide—CYP3A4—endocrine gland—stomach cancer	0.000409	0.0143	CbGeAlD
Ciclesonide—Weight increased—Docetaxel—stomach cancer	0.000404	0.00289	CcSEcCtD
Ciclesonide—CYP2D6—endocrine gland—stomach cancer	0.000403	0.014	CbGeAlD
Ciclesonide—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000399	0.00286	CcSEcCtD
Ciclesonide—Diabetes mellitus—Epirubicin—stomach cancer	0.000398	0.00285	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—stomach cancer	0.000398	0.00285	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—stomach cancer	0.000396	0.00284	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—stomach cancer	0.000396	0.00284	CcSEcCtD
Ciclesonide—Weight increased—Capecitabine—stomach cancer	0.000391	0.0028	CcSEcCtD
Ciclesonide—Prednisolone—CYP2A6—stomach cancer	0.00039	0.102	CrCbGaD
Ciclesonide—Cough—Irinotecan—stomach cancer	0.00039	0.0028	CcSEcCtD
Ciclesonide—Hypertension—Irinotecan—stomach cancer	0.000386	0.00277	CcSEcCtD
Ciclesonide—Pneumonia—Capecitabine—stomach cancer	0.000385	0.00276	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—stomach cancer	0.000385	0.00276	CcSEcCtD
Ciclesonide—Infestation NOS—Capecitabine—stomach cancer	0.000383	0.00274	CcSEcCtD
Ciclesonide—Infestation—Capecitabine—stomach cancer	0.000383	0.00274	CcSEcCtD
Ciclesonide—NR3C1—lymph node—stomach cancer	0.000374	0.013	CbGeAlD
Ciclesonide—Epistaxis—Docetaxel—stomach cancer	0.000373	0.00267	CcSEcCtD
Ciclesonide—Conjunctivitis—Capecitabine—stomach cancer	0.000372	0.00267	CcSEcCtD
Ciclesonide—Urinary tract infection—Capecitabine—stomach cancer	0.000372	0.00267	CcSEcCtD
Ciclesonide—CYP3A4—liver—stomach cancer	0.000369	0.0128	CbGeAlD
Ciclesonide—Diabetes mellitus—Doxorubicin—stomach cancer	0.000368	0.00264	CcSEcCtD
Ciclesonide—Chest pain—Fluorouracil—stomach cancer	0.000365	0.00261	CcSEcCtD
Ciclesonide—CYP2D6—liver—stomach cancer	0.000363	0.0126	CbGeAlD
Ciclesonide—Infection—Irinotecan—stomach cancer	0.000363	0.0026	CcSEcCtD
Ciclesonide—Epistaxis—Capecitabine—stomach cancer	0.000361	0.00259	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—stomach cancer	0.000357	0.00256	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—stomach cancer	0.000356	0.00255	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—stomach cancer	0.000355	0.00255	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—stomach cancer	0.000352	0.00253	CcSEcCtD
Ciclesonide—Infection—Fluorouracil—stomach cancer	0.000347	0.00249	CcSEcCtD
Ciclesonide—Pain in extremity—Epirubicin—stomach cancer	0.000346	0.00248	CcSEcCtD
Ciclesonide—Haemoglobin—Capecitabine—stomach cancer	0.000346	0.00248	CcSEcCtD
Ciclesonide—Rhinitis—Capecitabine—stomach cancer	0.000345	0.00247	CcSEcCtD
Ciclesonide—Haemorrhage—Capecitabine—stomach cancer	0.000344	0.00246	CcSEcCtD
Ciclesonide—Pharyngitis—Capecitabine—stomach cancer	0.000341	0.00245	CcSEcCtD
Ciclesonide—Face oedema—Epirubicin—stomach cancer	0.000334	0.0024	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—stomach cancer	0.000331	0.00662	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PLIN2—stomach cancer	0.00033	0.00662	CbGpPWpGaD
Ciclesonide—Dyspnoea—Irinotecan—stomach cancer	0.000325	0.00233	CcSEcCtD
Ciclesonide—Dyspepsia—Irinotecan—stomach cancer	0.000321	0.0023	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—stomach cancer	0.000321	0.0023	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—stomach cancer	0.00032	0.0023	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—stomach cancer	0.00032	0.00229	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000318	0.00228	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000315	0.00226	CcSEcCtD
Ciclesonide—Fatigue—Irinotecan—stomach cancer	0.000315	0.00226	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—FGG—stomach cancer	0.000314	0.00629	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HBEGF—stomach cancer	0.000314	0.00628	CbGpPWpGaD
Ciclesonide—Dyspnoea—Fluorouracil—stomach cancer	0.000312	0.00223	CcSEcCtD
Ciclesonide—Immune system disorder—Capecitabine—stomach cancer	0.000311	0.00223	CcSEcCtD
Ciclesonide—Mediastinal disorder—Capecitabine—stomach cancer	0.00031	0.00222	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—stomach cancer	0.00031	0.00222	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—stomach cancer	0.000309	0.00222	CcSEcCtD
Ciclesonide—Dyspepsia—Fluorouracil—stomach cancer	0.000308	0.00221	CcSEcCtD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000307	0.00615	CbGpPWpGaD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000305	0.00219	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—stomach cancer	0.000303	0.00217	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000302	0.00216	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—stomach cancer	0.000299	0.00214	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—stomach cancer	0.000299	0.00214	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000297	0.00213	CcSEcCtD
Ciclesonide—Dysgeusia—Capecitabine—stomach cancer	0.000293	0.0021	CcSEcCtD
Ciclesonide—Back pain—Capecitabine—stomach cancer	0.00029	0.00207	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—stomach cancer	0.000288	0.00206	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—SERPINE1—stomach cancer	0.000287	0.00576	CbGpPWpGaD
Ciclesonide—Pneumonia—Methotrexate—stomach cancer	0.000287	0.00206	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—stomach cancer	0.000286	0.00205	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—stomach cancer	0.000285	0.00204	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—stomach cancer	0.000285	0.00204	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000283	0.00202	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—stomach cancer	0.000282	0.00565	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—GSTP1—stomach cancer	0.000278	0.00557	CbGpPWpGaD
Ciclesonide—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000278	0.00199	CcSEcCtD
Ciclesonide—Urticaria—Fluorouracil—stomach cancer	0.000278	0.00199	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—stomach cancer	0.000277	0.00199	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—stomach cancer	0.000277	0.00198	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—HMOX1—stomach cancer	0.000274	0.0055	CbGpPWpGaD
Ciclesonide—Palpitations—Docetaxel—stomach cancer	0.000273	0.00196	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—stomach cancer	0.000272	0.00195	CcSEcCtD
Ciclesonide—Cough—Docetaxel—stomach cancer	0.00027	0.00193	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—stomach cancer	0.000269	0.00193	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—stomach cancer	0.000268	0.00192	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—stomach cancer	0.000268	0.00538	CbGpPWpGaD
Ciclesonide—Hypertension—Docetaxel—stomach cancer	0.000267	0.00191	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—stomach cancer	0.000267	0.00191	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—stomach cancer	0.000267	0.00191	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—stomach cancer	0.000266	0.00191	CcSEcCtD
Ciclesonide—Palpitations—Capecitabine—stomach cancer	0.000265	0.0019	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—stomach cancer	0.000263	0.00189	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—stomach cancer	0.000263	0.00189	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—ZNF559—stomach cancer	0.000263	0.00526	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—ADRB1—stomach cancer	0.000263	0.00526	CbGpPWpGaD
Ciclesonide—Asthenia—Irinotecan—stomach cancer	0.000262	0.00188	CcSEcCtD
Ciclesonide—Cough—Capecitabine—stomach cancer	0.000261	0.00187	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—stomach cancer	0.000259	0.00186	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—stomach cancer	0.000259	0.00186	CcSEcCtD
Ciclesonide—Hypertension—Capecitabine—stomach cancer	0.000258	0.00185	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—stomach cancer	0.000257	0.00184	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000257	0.00184	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—stomach cancer	0.000257	0.00184	CcSEcCtD
Ciclesonide—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000257	0.00514	CbGpPWpGaD
Ciclesonide—Haemorrhage—Methotrexate—stomach cancer	0.000256	0.00183	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTM1—stomach cancer	0.000256	0.00512	CbGpPWpGaD
Ciclesonide—Arthralgia—Capecitabine—stomach cancer	0.000255	0.00183	CcSEcCtD
Ciclesonide—Chest pain—Capecitabine—stomach cancer	0.000255	0.00183	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—stomach cancer	0.000254	0.00182	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—stomach cancer	0.000252	0.00181	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—stomach cancer	0.000252	0.0018	CcSEcCtD
Ciclesonide—Infection—Docetaxel—stomach cancer	0.000251	0.0018	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—stomach cancer	0.00025	0.00179	CcSEcCtD
Ciclesonide—Dry mouth—Capecitabine—stomach cancer	0.000249	0.00179	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—stomach cancer	0.000248	0.00178	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—stomach cancer	0.000247	0.00177	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—stomach cancer	0.000247	0.00177	CcSEcCtD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000247	0.00495	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—stomach cancer	0.000243	0.00486	CbGpPWpGaD
Ciclesonide—Infection—Capecitabine—stomach cancer	0.000243	0.00174	CcSEcCtD
Ciclesonide—Dizziness—Irinotecan—stomach cancer	0.000241	0.00173	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—stomach cancer	0.000241	0.00173	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—stomach cancer	0.00024	0.00172	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—stomach cancer	0.00024	0.00172	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—stomach cancer	0.00024	0.00172	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—stomach cancer	0.00024	0.00172	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—stomach cancer	0.000238	0.0017	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN1B—stomach cancer	0.000238	0.00476	CbGpPWpGaD
Ciclesonide—Epistaxis—Doxorubicin—stomach cancer	0.000233	0.00167	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—stomach cancer	0.000232	0.00465	CbGpPWpGaD
Ciclesonide—Sinusitis—Doxorubicin—stomach cancer	0.000232	0.00166	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—RORA—stomach cancer	0.000232	0.00464	CbGpPWpGaD
Ciclesonide—Immune system disorder—Methotrexate—stomach cancer	0.000231	0.00166	CcSEcCtD
Ciclesonide—Dizziness—Fluorouracil—stomach cancer	0.000231	0.00166	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—stomach cancer	0.000231	0.00165	CcSEcCtD
Ciclesonide—Rash—Irinotecan—stomach cancer	0.00023	0.00165	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—stomach cancer	0.00023	0.00165	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00023	0.00165	CcSEcCtD
Ciclesonide—Headache—Irinotecan—stomach cancer	0.000229	0.00164	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—stomach cancer	0.000225	0.00161	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—stomach cancer	0.000223	0.0016	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—stomach cancer	0.000223	0.00446	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000223	0.00159	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—stomach cancer	0.000222	0.00159	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—stomach cancer	0.000222	0.00159	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—stomach cancer	0.000222	0.00159	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—stomach cancer	0.00022	0.00158	CcSEcCtD
Ciclesonide—Dermatitis—Fluorouracil—stomach cancer	0.00022	0.00158	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—stomach cancer	0.00022	0.00158	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN1A—stomach cancer	0.000219	0.00439	CbGpPWpGaD
Ciclesonide—Headache—Fluorouracil—stomach cancer	0.000219	0.00157	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—stomach cancer	0.000219	0.00438	CbGpPWpGaD
Ciclesonide—Dysgeusia—Methotrexate—stomach cancer	0.000218	0.00156	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000218	0.00156	CcSEcCtD
Ciclesonide—Dyspnoea—Capecitabine—stomach cancer	0.000218	0.00156	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—stomach cancer	0.000218	0.00156	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—stomach cancer	0.000217	0.00155	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—stomach cancer	0.000216	0.00155	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	0.000216	0.00433	CbGpPWpGaD
Ciclesonide—Mediastinal disorder—Epirubicin—stomach cancer	0.000216	0.00155	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—stomach cancer	0.000216	0.00154	CcSEcCtD
Ciclesonide—Dyspepsia—Capecitabine—stomach cancer	0.000215	0.00154	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—stomach cancer	0.000214	0.00429	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000211	0.00151	CcSEcCtD
Ciclesonide—Fatigue—Capecitabine—stomach cancer	0.000211	0.00151	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—stomach cancer	0.000208	0.00417	CbGpPWpGaD
Ciclesonide—Nausea—Fluorouracil—stomach cancer	0.000208	0.00149	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—AHR—stomach cancer	0.000207	0.00415	CbGpPWpGaD
Ciclesonide—Dysgeusia—Epirubicin—stomach cancer	0.000204	0.00146	CcSEcCtD
Ciclesonide—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000202	0.00405	CbGpPWpGaD
Ciclesonide—Back pain—Epirubicin—stomach cancer	0.000202	0.00145	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.0002	0.00401	CbGpPWpGaD
Ciclesonide—Immune system disorder—Doxorubicin—stomach cancer	0.0002	0.00143	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—RORA—stomach cancer	0.0002	0.00401	CbGpPWpGaD
Ciclesonide—Mediastinal disorder—Doxorubicin—stomach cancer	0.0002	0.00143	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—ZNF160—stomach cancer	0.000199	0.00399	CbGpPWpGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—stomach cancer	0.000197	0.00395	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.000196	0.00392	CbGpPWpGaD
Ciclesonide—Cough—Methotrexate—stomach cancer	0.000194	0.00139	CcSEcCtD
Ciclesonide—Urticaria—Capecitabine—stomach cancer	0.000194	0.00139	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—SMAD4—stomach cancer	0.000193	0.00387	CbGpPWpGaD
Ciclesonide—Chest pain—Methotrexate—stomach cancer	0.00019	0.00136	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—stomach cancer	0.00019	0.00136	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—stomach cancer	0.000189	0.00135	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—stomach cancer	0.000187	0.00134	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—stomach cancer	0.000184	0.00132	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.000184	0.00368	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL10—stomach cancer	0.000183	0.00367	CbGpPWpGaD
Ciclesonide—Cough—Epirubicin—stomach cancer	0.000182	0.0013	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—MYC—stomach cancer	0.000182	0.00364	CbGpPWpGaD
Ciclesonide—Asthenia—Docetaxel—stomach cancer	0.000181	0.0013	CcSEcCtD
Ciclesonide—Infection—Methotrexate—stomach cancer	0.000181	0.00129	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—stomach cancer	0.00018	0.00129	CcSEcCtD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.00018	0.0036	CbGpPWpGaD
Ciclesonide—Chest pain—Epirubicin—stomach cancer	0.000178	0.00127	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—stomach cancer	0.000178	0.00127	CcSEcCtD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000176	0.00353	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—stomach cancer	0.000176	0.00353	CbGpPWpGaD
Ciclesonide—Asthenia—Capecitabine—stomach cancer	0.000175	0.00126	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—stomach cancer	0.000174	0.00124	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—BMP2—stomach cancer	0.000172	0.00344	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—stomach cancer	0.000171	0.00343	CbGpPWpGaD
Ciclesonide—Palpitations—Doxorubicin—stomach cancer	0.000171	0.00122	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—stomach cancer	0.000169	0.00339	CbGpPWpGaD
Ciclesonide—Infection—Epirubicin—stomach cancer	0.000169	0.00121	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—stomach cancer	0.000168	0.00121	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—stomach cancer	0.000168	0.00337	CbGpPWpGaD
Ciclesonide—Dizziness—Docetaxel—stomach cancer	0.000167	0.0012	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—stomach cancer	0.000167	0.00119	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000166	0.00119	CcSEcCtD
Ciclesonide—Prednisone—ALB—stomach cancer	0.000165	0.0431	CrCbGaD
Ciclesonide—Arthralgia—Doxorubicin—stomach cancer	0.000164	0.00118	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—stomach cancer	0.000164	0.00118	CcSEcCtD
Ciclesonide—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000163	0.00327	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—stomach cancer	0.000163	0.00327	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000163	0.00327	CbGpPWpGaD
Ciclesonide—Dyspnoea—Methotrexate—stomach cancer	0.000162	0.00116	CcSEcCtD
Ciclesonide—Dizziness—Capecitabine—stomach cancer	0.000162	0.00116	CcSEcCtD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000161	0.00322	CbGpPWpGaD
Ciclesonide—Dry mouth—Doxorubicin—stomach cancer	0.000161	0.00115	CcSEcCtD
Ciclesonide—Dyspepsia—Methotrexate—stomach cancer	0.00016	0.00115	CcSEcCtD
Ciclesonide—Rash—Docetaxel—stomach cancer	0.000159	0.00114	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—stomach cancer	0.000159	0.00114	CcSEcCtD
Ciclesonide—Headache—Docetaxel—stomach cancer	0.000158	0.00113	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000157	0.00113	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—stomach cancer	0.000157	0.00112	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—stomach cancer	0.000156	0.00112	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000155	0.00111	CcSEcCtD
Ciclesonide—Rash—Capecitabine—stomach cancer	0.000154	0.0011	CcSEcCtD
Ciclesonide—Dermatitis—Capecitabine—stomach cancer	0.000154	0.0011	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—GADD45A—stomach cancer	0.000154	0.00308	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PLAU—stomach cancer	0.000153	0.00307	CbGpPWpGaD
Ciclesonide—Headache—Capecitabine—stomach cancer	0.000153	0.0011	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—stomach cancer	0.000152	0.00109	CcSEcCtD
Ciclesonide—Nausea—Docetaxel—stomach cancer	0.00015	0.00107	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—stomach cancer	0.00015	0.00107	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000147	0.00105	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—stomach cancer	0.000147	0.00105	CcSEcCtD
Ciclesonide—Nausea—Capecitabine—stomach cancer	0.000145	0.00104	CcSEcCtD
Ciclesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000145	0.0029	CbGpPWpGaD
Ciclesonide—Urticaria—Methotrexate—stomach cancer	0.000144	0.00104	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.000144	0.00289	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—SERPINE1—stomach cancer	0.000144	0.00288	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000143	0.00103	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—stomach cancer	0.000142	0.00285	CbGpPWpGaD
Ciclesonide—Dyspnoea—Doxorubicin—stomach cancer	0.00014	0.00101	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—APC—stomach cancer	0.000139	0.00279	CbGpPWpGaD
Ciclesonide—Dyspepsia—Doxorubicin—stomach cancer	0.000139	0.000993	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000136	0.000974	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—stomach cancer	0.000136	0.000973	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—stomach cancer	0.000135	0.000969	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.000135	0.0027	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000132	0.00265	CbGpPWpGaD
Ciclesonide—Asthenia—Methotrexate—stomach cancer	0.00013	0.000935	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.000129	0.00258	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ZNF559—stomach cancer	0.000126	0.00253	CbGpPWpGaD
Ciclesonide—Urticaria—Doxorubicin—stomach cancer	0.000125	0.000896	CcSEcCtD
Ciclesonide—Asthenia—Epirubicin—stomach cancer	0.000122	0.000875	CcSEcCtD
Ciclesonide—Dizziness—Methotrexate—stomach cancer	0.00012	0.000862	CcSEcCtD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—JUN—stomach cancer	0.000116	0.00233	CbGpPWpGaD
Ciclesonide—Rash—Methotrexate—stomach cancer	0.000115	0.000822	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—stomach cancer	0.000115	0.000821	CcSEcCtD
Ciclesonide—Headache—Methotrexate—stomach cancer	0.000114	0.000816	CcSEcCtD
Ciclesonide—Asthenia—Doxorubicin—stomach cancer	0.000113	0.00081	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—stomach cancer	0.000113	0.000806	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—stomach cancer	0.000111	0.00222	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—stomach cancer	0.00011	0.00221	CbGpPWpGaD
Ciclesonide—Nausea—Methotrexate—stomach cancer	0.000108	0.000774	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—PRPF19—stomach cancer	0.000108	0.00215	CbGpPWpGaD
Ciclesonide—Rash—Epirubicin—stomach cancer	0.000107	0.000769	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—stomach cancer	0.000107	0.000768	CcSEcCtD
Ciclesonide—Headache—Epirubicin—stomach cancer	0.000107	0.000764	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000107	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.000105	0.00211	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000105	0.00211	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—RXRB—stomach cancer	0.000105	0.00209	CbGpPWpGaD
Ciclesonide—Dizziness—Doxorubicin—stomach cancer	0.000104	0.000746	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.000101	0.00203	CbGpPWpGaD
Ciclesonide—Nausea—Epirubicin—stomach cancer	0.000101	0.000724	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—stomach cancer	0.0001	0.00201	CbGpPWpGaD
Ciclesonide—Rash—Doxorubicin—stomach cancer	9.93e-05	0.000712	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—stomach cancer	9.92e-05	0.000711	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—stomach cancer	9.86e-05	0.000707	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN1B—stomach cancer	9.8e-05	0.00196	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—stomach cancer	9.66e-05	0.00194	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ZNF160—stomach cancer	9.58e-05	0.00192	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IRS2—stomach cancer	9.4e-05	0.00188	CbGpPWpGaD
Ciclesonide—Nausea—Doxorubicin—stomach cancer	9.35e-05	0.00067	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—stomach cancer	9.34e-05	0.00187	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUN—stomach cancer	9.33e-05	0.00187	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—stomach cancer	9.07e-05	0.00182	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—stomach cancer	8.84e-05	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EEF1A2—stomach cancer	8.77e-05	0.00176	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	8.64e-05	0.00173	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6ST—stomach cancer	8.64e-05	0.00173	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	8.46e-05	0.00169	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	8.3e-05	0.00166	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	8.22e-05	0.00165	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	8.04e-05	0.00161	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—stomach cancer	8.01e-05	0.0016	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	7.97e-05	0.0016	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	7.77e-05	0.00156	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	7.75e-05	0.00155	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	7.56e-05	0.00151	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	7.5e-05	0.0015	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HNRNPL—stomach cancer	7.26e-05	0.00145	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SERPINE1—stomach cancer	7.22e-05	0.00145	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—stomach cancer	7.1e-05	0.00142	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2A6—stomach cancer	7.02e-05	0.00141	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EEF1A1—stomach cancer	6.93e-05	0.00139	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	6.79e-05	0.00136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—AKR1C3—stomach cancer	6.74e-05	0.00135	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	6.67e-05	0.00134	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	6.66e-05	0.00133	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	6.46e-05	0.00129	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	6.16e-05	0.00123	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EXOSC5—stomach cancer	5.98e-05	0.0012	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CPSF1—stomach cancer	5.98e-05	0.0012	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—POLR3K—stomach cancer	5.81e-05	0.00116	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CDKN1A—stomach cancer	5.51e-05	0.0011	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	5.42e-05	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	5.28e-05	0.00106	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	5.07e-05	0.00102	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RXRB—stomach cancer	5.03e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	4.96e-05	0.000994	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL13—stomach cancer	4.94e-05	0.000989	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL18—stomach cancer	4.94e-05	0.000989	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—stomach cancer	4.92e-05	0.000986	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—stomach cancer	4.92e-05	0.000985	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	4.91e-05	0.000984	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—stomach cancer	4.86e-05	0.000973	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—stomach cancer	4.64e-05	0.00093	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS15—stomach cancer	4.6e-05	0.000922	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS21—stomach cancer	4.6e-05	0.000922	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	4.59e-05	0.000919	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SNRPB—stomach cancer	4.53e-05	0.000908	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—stomach cancer	4.52e-05	0.000906	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—stomach cancer	4.46e-05	0.000894	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	4.4e-05	0.000882	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	4.29e-05	0.00086	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—stomach cancer	4.26e-05	0.000852	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACAD8—stomach cancer	4.23e-05	0.000848	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	4.21e-05	0.000842	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RORA—stomach cancer	4.07e-05	0.000816	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT3B—stomach cancer	3.82e-05	0.000764	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GMPR2—stomach cancer	3.77e-05	0.000756	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL15—stomach cancer	3.74e-05	0.000749	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	3.68e-05	0.000737	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RARB—stomach cancer	3.64e-05	0.000729	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS26—stomach cancer	3.49e-05	0.000699	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH3B—stomach cancer	3.45e-05	0.000691	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SUCLG1—stomach cancer	3.45e-05	0.000691	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—stomach cancer	3.43e-05	0.000688	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—stomach cancer	3.22e-05	0.000645	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NDUFS1—stomach cancer	3.21e-05	0.000643	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NDUFV1—stomach cancer	3.21e-05	0.000643	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	3.17e-05	0.000636	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPB1—stomach cancer	3.05e-05	0.000611	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	2.97e-05	0.000594	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS19—stomach cancer	2.97e-05	0.000594	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.96e-05	0.000592	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	2.93e-05	0.000586	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.92e-05	0.000584	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PGLS—stomach cancer	2.86e-05	0.000573	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BLVRB—stomach cancer	2.86e-05	0.000573	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT1—stomach cancer	2.84e-05	0.000568	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA8—stomach cancer	2.8e-05	0.00056	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACAD8—stomach cancer	2.77e-05	0.000554	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.73e-05	0.000546	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	2.64e-05	0.000528	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS6—stomach cancer	2.62e-05	0.000526	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GMPR2—stomach cancer	2.47e-05	0.000494	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FBP1—stomach cancer	2.43e-05	0.000487	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA1—stomach cancer	2.43e-05	0.000487	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.43e-05	0.000487	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CKB—stomach cancer	2.43e-05	0.000487	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLIN2—stomach cancer	2.29e-05	0.000458	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH3B—stomach cancer	2.26e-05	0.000452	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.26e-05	0.000452	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA2—stomach cancer	2.22e-05	0.000445	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPP2R1A—stomach cancer	2.18e-05	0.000437	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NT5E—stomach cancer	2.17e-05	0.000434	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PGAM1—stomach cancer	2.17e-05	0.000434	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.1e-05	0.00042	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.1e-05	0.00042	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH7A1—stomach cancer	2.07e-05	0.000414	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLCE1—stomach cancer	2.07e-05	0.000414	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SMAD4—stomach cancer	2.02e-05	0.000406	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UMPS—stomach cancer	1.98e-05	0.000397	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PGLS—stomach cancer	1.87e-05	0.000374	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BLVRB—stomach cancer	1.87e-05	0.000374	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ERCC2—stomach cancer	1.85e-05	0.00037	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PDHA1—stomach cancer	1.84e-05	0.000369	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ECHS1—stomach cancer	1.84e-05	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.78e-05	0.000357	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMP—stomach cancer	1.73e-05	0.000347	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FADS1—stomach cancer	1.73e-05	0.000347	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	1.67e-05	0.000334	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SREBF2—stomach cancer	1.62e-05	0.000325	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RORA—stomach cancer	1.6e-05	0.000321	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FBP1—stomach cancer	1.59e-05	0.000318	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.59e-05	0.000318	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CKB—stomach cancer	1.59e-05	0.000318	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA1—stomach cancer	1.59e-05	0.000318	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDOB—stomach cancer	1.5e-05	0.000301	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLIN2—stomach cancer	1.49e-05	0.000299	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA2—stomach cancer	1.45e-05	0.000291	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NT5E—stomach cancer	1.42e-05	0.000284	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PGAM1—stomach cancer	1.42e-05	0.000284	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—stomach cancer	1.41e-05	0.000282	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALOX5—stomach cancer	1.4e-05	0.00028	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DPYD—stomach cancer	1.37e-05	0.000275	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLCE1—stomach cancer	1.35e-05	0.000271	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.35e-05	0.000271	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UMPS—stomach cancer	1.3e-05	0.00026	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—stomach cancer	1.27e-05	0.000254	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—stomach cancer	1.21e-05	0.000243	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PDHA1—stomach cancer	1.2e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ECHS1—stomach cancer	1.2e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.2e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.17e-05	0.000234	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO1—stomach cancer	1.14e-05	0.000228	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMP—stomach cancer	1.13e-05	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FADS1—stomach cancer	1.13e-05	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SREBF2—stomach cancer	1.06e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RORA—stomach cancer	1.05e-05	0.00021	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD44—stomach cancer	1.01e-05	0.000202	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDOB—stomach cancer	9.82e-06	0.000197	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALOX5—stomach cancer	9.13e-06	0.000183	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DPYD—stomach cancer	8.98e-06	0.00018	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPP2R1A—stomach cancer	8.58e-06	0.000172	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—stomach cancer	8.42e-06	0.000169	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—stomach cancer	8.3e-06	0.000166	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—stomach cancer	8.26e-06	0.000165	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—stomach cancer	8.03e-06	0.000161	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—stomach cancer	7.94e-06	0.000159	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2A6—stomach cancer	7.85e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—stomach cancer	7.83e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—stomach cancer	7.74e-06	0.000155	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.64e-06	0.000153	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO1—stomach cancer	7.44e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ERCC2—stomach cancer	7.27e-06	0.000146	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—stomach cancer	6.84e-06	0.000137	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD44—stomach cancer	6.6e-06	0.000132	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—stomach cancer	6.31e-06	0.000126	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA1—stomach cancer	6.29e-06	0.000126	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.61e-06	0.000112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—stomach cancer	5.54e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—stomach cancer	5.5e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—stomach cancer	5.43e-06	0.000109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—stomach cancer	5.12e-06	0.000103	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—stomach cancer	5.06e-06	0.000101	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—stomach cancer	4.99e-06	9.99e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—stomach cancer	4.77e-06	9.55e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ERCC2—stomach cancer	4.76e-06	9.53e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—stomach cancer	4.47e-06	8.95e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—stomach cancer	4.36e-06	8.74e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—stomach cancer	4.12e-06	8.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA1—stomach cancer	4.11e-06	8.24e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—stomach cancer	3.63e-06	7.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—stomach cancer	3.26e-06	6.53e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—stomach cancer	3.12e-06	6.25e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—stomach cancer	2.85e-06	5.71e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.68e-06	5.38e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.75e-06	3.51e-05	CbGpPWpGaD
